Records containing: HIV-1-infection
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-09-04Testing the Efficacy and Mechanisms of an Adapted Resilience Building Intervention in People Aging With HIV
-
CLINICAL_TRIALS study results posted · 2026-09-01Expedited Partner Therapy and the HIV Prevention Cascade for MSM in Peru
-
CLINICAL_TRIALS study results posted · 2026-08-05Population Effectiveness of Dolutegravir Implementation in Sub-Saharan Africa: A Prospective Observational Cohort Study
-
CLINICAL_TRIALS study record update · 2026-06-18Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV
-
CLINICAL_TRIALS study results posted · 2026-06-09SYV: A Mental Health Intervention to Improve HIV Outcomes in Tanzanian Youth
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-06-04A Phase 2/3, Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1
-
CLINICAL_TRIALS study record update · 2026-04-24A Phase 2, Open-label, Single-Arm Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Long-Acting Lenacapavir in Combination With an Optimized Background Regimen in Treatment-experienced Adolescents and Children With HIV-1
-
CLINICAL_TRIALS study record update · 2026-04-20Phase I/II Study of the Safety, Tolerability, Acceptability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living With HIV-1, Two to Less Than 12 Years of Age
-
CLINICAL_TRIALS study record update · 2026-04-15A Phase 1b Study to Evaluate the Safety and Pharmacokinetics of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Neonates Exposed to HIV-1
-
CLINICAL_TRIALS study record update · 2026-04-15An Operationally Seamless Phase 2/3, Randomized, Active-Controlled Study Evaluating the Safety and Efficacy of an Oral Weekly Regimen of GS-1720 in Combination With GS-4182 Versus Biktarvy in Treatment-Naive People With HIV-1
-
CLINICAL_TRIALS study record update · 2026-04-13Efficacy, Safety and Tolerability of Switching to DTG/3TC Single Tablet Regimen From B/F/TAF in Older Persons Living With HIV in Kenya
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of Priming Regimens of 426c.Mod.Core-C4b and Optional Boost Regimen With HIV Trimer BG505 SOSIP.GT1.1 gp140, Both Adjuvanted With 3M-052-AF + Alum in Healthy, Adult Participants Without HIV
-
CLINICAL_TRIALS study record update · 2026-04-07Effects of Mu-opiate Receptor Engagement on Microbial Translocation and Residual Immune Activation in HIV-infected, ART Suppressed Opioid Use Disorder Patients Initiating Medication-assisted Treatment
-
CLINICAL_TRIALS study record update · 2026-04-07A Phase I, Randomized, Placebo-Controlled Study of the Safety, Antiviral & Immunomodulatory Activity of Broadly Neutralizing Antibodies 3BNC117-LS-J and 10-1074-LS-J in Combination in ART-treated Adults in Sub-Saharan Africa Living With HIV During a Monitored Analytical Treatment Interruption
-
CLINICAL_TRIALS study record update · 2026-04-03A Phase I Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection
-
CLINICAL_TRIALS study record update · 2026-03-30Addressing Barriers to Anti-hypertensive Medication Adherence Among Persons Living With HIV Who Have Achieved Viral Suppression
-
CLINICAL_TRIALS study record update · 2026-03-27Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States
-
CLINICAL_TRIALS study record update · 2026-03-16An Open-label, Single-arm Study to Provide Continued Access to Study Drug to Participants Who Have Completed Pediatric Clinical Studies Involving Gilead HIV Treatments
-
CLINICAL_TRIALS study record update · 2026-03-11A Phase 2a, Randomized, Double-Blinded, Placebo-Controlled, Multicenter Study to Investigate the Antiviral Effect, Safety, Tolerability, and Pharmacokinetics of STP0404 in Adults With HIV-1 Infection
-
CLINICAL_TRIALS study record update · 2026-03-05An Umbrella Phase 1b, Open-label, Multi-Cohort Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Novel Antiretrovirals in Participants With HIV-1 Substudy-05: GS-3242
-
CLINICAL_TRIALS study record update · 2026-02-19Simplifying Treatment and Monitoring for HIV (STREAM HIV): Point-of-Care Urine Tenofovir Adherence and Viral Load Testing to Improve HIV Outcomes in South Africa
-
CLINICAL_TRIALS study record update · 2026-02-17Supporting Treatment Adherence for Resilience and Thriving
-
CLINICAL_TRIALS study record update · 2026-02-11A Phase 4 Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Oral B/F/TAF After Discontinuing Injectable CAB + RPV
-
CLINICAL_TRIALS study record update · 2026-02-09A Phase I/IIa Randomized, Placebo-Controlled Trial of Conserved-Mosaic T-cell Vaccine in a Regimen With Vesatolimod and Broadly Neutralizing Antibodies in Adults Initiated on Suppressive Antiretroviral Therapy During Acute HIV-1
-
CLINICAL_TRIALS study record update · 2026-02-06Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)